Fair Money & Economic Opportunity

Theratechnologies Inc. is a specialty pharmaceutical company focused on developing and commercializing therapies. The company's core business involves medications for HIV and related complications.

It does not offer lending, deposit, insurance, or other financial services to consumers. While articles mention patient financial assistance programs for drug costs, these are not considered financial products or services as defined by the 'Fair Money & Economic Opportunity' value, which focuses on how financial institutions democratize access to fair financial services. Therefore, all KPIs related to financial products, services, and their associated metrics are not applicable to its business model.

Fair Pay & Worker Respect

No specific, quantitative data points were found across the provided articles for most of the KPIs related to Fair Pay & Worker Respect. However, multiple articles (Articles 3, 4, 8, 9) explicitly state that no regulatory actions, violations, fines, or compliance issues are mentioned in employee reviews or company summaries.

This indicates no significant infractions in the past year, aligning with a score of -10 for labor violation incidents.

Fair Trade & Ethical Sourcing

The provided articles do not contain specific, quantifiable data points for any of the Fair Trade & Ethical Sourcing KPIs. While the company's FY2023 annual report states no instances of forced labor or child labor were identified in its supply chain for that year

, this does not cover the three-year period required by the KPI. The company also indicates it has a Code of Business Conduct and Ethics, a Supplier SOP, and has mapped its EGRIFTA SV® supply chain to assess risks, and conducted audits of service providers involved in GMP activities. However, these statements lack the specific percentages, frequencies, or numbers required to score the respective KPIs, such as fair-trade certification share, audit frequency, traceability coverage, ethical clause coverage in supplier contracts, or remediation speed.

Honest & Fair Business

Theratechnologies Inc. has a Code of Ethics that outlines reporting procedures for whistleblowers to the Vice-President of Legal Affairs or Human Resources.

The company also provides a compliance hotline (1-877-267-0256) with options for anonymity, and all U.S. employees interacting with company operations receive training on the Code and related policies. The company maintains a comprehensive U.S. Compliance Program, which includes a Chief Compliance Officer, risk assessment, monitoring, and auditing activities. Its Code of Ethics prohibits fraudulent or illegal acts, including corruption, and the company commits to compliance with federal and state laws and industry standards like the PhRMA Code.

Kind to Animals

The provided articles state that Theratechnologies Inc. engages in animal testing, as confirmed by crueltyfreeinvesting.org and detailed in product information for EGRIFTA WR.

Animal studies were conducted on rodents, rats, and rabbits for mutagenicity, fertility, and developmental effects. These tests revealed adverse outcomes such as hydrocephaly and delayed skull ossification in rat offspring at certain doses. However, the articles do not provide specific quantitative data for any of the KPIs, such as the percentage of products certified cruelty-free, the extent of non-animal testing methods employed, the percentage of animal-related operations with humane certifications, the measurable impact of wildlife conservation initiatives, the percentage of animal-derived ingredients replaced, the percentage of suppliers audited for welfare, the percentage of animal products sourced from cage-free systems, the strength or scope of an animal testing policy, the annual volume of animals used in testing, the percentage of R&D budget invested in animal-free technologies, details on animal agriculture ethics, participation in animal-free R&D collaborations, or engagement in public policy for animal welfare. Therefore, no KPIs can be scored based on the available evidence.

No War, No Weapons

No specific, concrete data points were found in the provided articles regarding Theratechnologies Inc.'s involvement in arms manufacturing, military contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, or any other metrics related to the 'No War, No Weapons' ethical value.

The articles either focused on general industry trends, other companies, or explicitly stated that no relevant data for Theratechnologies Inc. was available for these metrics.

Planet-Friendly Business

The provided article focuses on corporate responsibility, ethical conduct, and community involvement but does not contain any quantitative data related to environmental performance metrics.

There are no mentions of specific targets, emissions, certifications, or other relevant data points for any of the Planet-Friendly Business KPIs.

Respect for Cultures & Communities

The provided articles do not contain any specific, concrete data points or information regarding Theratechnologies Inc.'s performance related to respect for cultures and communities. focuses on financial results and an acquisition, explicitly stating no relevant data for the requested metrics.

indicates data extraction limitations, preventing the retrieval of any quantitative or qualitative information. Therefore, no KPIs can be assessed based on the evidence provided.

Safe & Smart Tech

The company has no documented data breaches.

All employees interacting with U.S. business operations receive periodic training on the Code of Business Conduct & Ethics and related policies, with annual certification of understanding and compliance required from all employees, officers, and directors. The company states that personal information is retained only as long as necessary or permitted by law. Service providers are contractually bound to respect confidentiality and use personal information only for limited, provided purposes, without authorization to share or use for direct marketing. Users can unsubscribe from communications, review their personal information, request corrections, and withdraw consent, but the privacy notice does not detail comprehensive control options. The company implements physical, organizational, contractual, and technological security measures to protect personal information from loss, theft, unauthorized disclosure, copying, use, or modification. Theratechnologies was in material compliance with its comprehensive Compliance Program and California Health & Safety Code section 119402 as of December 31, 2025, and references compliance with GDPR for EU residents.